Rare diseases
Investigational molecules
Locations
Back to Austria316 clinical trials in Salzburg, Austria across 4 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Study on the Effects of Semaglutide for Weight Management in Children and Adolescents with Obesity or Overweight
AustriaStudy on the Safety and Effectiveness of Tenecteplase for Patients with Acute Ischemic Stroke and Incomplete Reperfusion After Mechanical Thrombectomy
AustriaStudy Comparing MK-7684A (Vibostolimab and Pembrolizumab) with Pembrolizumab for Adults and Children with High-Risk Stage II-IV Melanoma
AustriaStudy Comparing Darolutamide and Androgen Deprivation Therapy to Placebo and Androgen Deprivation Therapy in Men with High-Risk Prostate Cancer Recurrence
AustriaStudy Comparing Tisagenlecleucel with Standard Treatment for Adults with Relapsed or Refractory Follicular Lymphoma
AustriaStudy on ALLO-647 and ALLO-501A for Adults with Relapsed or Refractory Large B-Cell Lymphoma
AustriaStudy Comparing Axicabtagene Ciloleucel and Standard Treatment for Adults with High-Risk Large B-Cell Lymphoma
AustriaStudy on Ganaxolone for Patients with Refractory Status Epilepticus
AustriaStudy on Carfilzomib and Ibrutinib for Patients with Waldenström’s Macroglobulinemia
AustriaStudy of Isatuximab with Lenalidomide and Dexamethasone for Elderly Patients (70+) with Newly Diagnosed Multiple Myeloma
AustriaStudy Comparing Carboplatin and Cisplatin for Patients with Extracranial Malignant Germ Cell Tumors
AustriaStudy on Elotuzumab, Carfilzomib, Lenalidomide, and Dexamethasone for Patients with Newly Diagnosed Multiple Myeloma
AustriaThe busiest research cities in the country
What the registry says about research in the country
Comprehensive studies focusing on metastatic cancers and innovative treatment approaches, including trials investigating new therapies for prostate cancer, colorectal cancer, and bladder cancer.
Multiple clinical trials evaluating targeted therapies and combination treatments for various stages of cancer progression.
Investigating breakthrough treatments for multiple myeloma and acute myeloid leukemia, with emphasis on innovative therapeutic combinations and targeted approaches.
Focus on improving outcomes for patients with various blood disorders through advanced therapeutic strategies.
Research initiatives addressing cardiovascular disease, Crohn's disease, and Alzheimer's disease, exploring new treatment modalities and therapeutic approaches.
Comprehensive studies aimed at developing more effective treatments for chronic conditions affecting quality of life.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
